SEBMF Welcomes Dr. Fumi Suzuki, Family Medicine Physician

Posted on Aug 11, 2015

drsuzuki websiteFumi Suzuki, M.D., MPH, is now seeing patients at our Albany Care Center. Dr. Suzuki is board certified in family medicine. Prior to joining SEBMF, Dr. Suzuki was the Chief Medical Officer of the Native American Health Center in San Francisco and Oakland. Welcome Dr. Suzuki!

SEBMF Welcomes Neurologist Gulmohor Roy, M.D.

Posted on Aug 5, 2015

drroy-106Neurologist Gulmohor Roy, M.D. is now seeing patients at our Antioch and Berkeley Care Centers. Dr. Roy is fellowship trained and Board eligible in Clinical Neurophysiology and Neuromuscular Medicine. She specializes in treating patients with peripheral nerve disorders, epilepsy headache disorders , multiple sclerosis, Parkinson’s, tremor and stroke. Welcome Dr. Roy!

Ask the Expert: Are You at Risk for a Urinary Tract Infection?

Posted on Jul 27, 2015


Jonathan Lynne, M.D., MPH, Family Medicine, Sutter East Bay Medical Foundation

Q: I’ve heard urinary tract infections (UTIs) are getting harder to treat. Why is this and who’s at risk of developing one?

Jonathan Lynne, M.D., MPH, answered:

UTIs are one of the most common infections doctors treat: More than half of women living in the United States will get a UTI. Urinary tract infections are caused by microorganisms—usually bacteria—that enter the urethra and bladder, causing inflammation and infection. UTIs are more common in women because women have a shorter urethra than men do. That means bacteria travel a shorter dAistance to a woman’s bladder. Read More

Sutter Urgent Care Antioch Celebrates 4th Anniversary

Posted on Jul 21, 2015

Bluerock UC staff

Staff members celebrated the UC Bluerock anniversary with a Minions themed party.

Sutter Urgent Care Antioch is celebrating four years of serving the East Contra Costa community and is dedicated to providing high quality, accessible and affordable care for patients in the East Bay. The facility treated about 100 patients a month when they first opened and now care for more than 700 patients a month.

“I’m very proud of what we’ve been able to accomplish in a short amount of time,” says Urgent Care Medical Director Jeffrey Leinen, M.D., FACEP. “We’ve been able to increase the scope of care by offering imaging and lab services. Providing episodic care is one of the cornerstones of how patients now receive health care.” Read More

Sutter Health’s 2014 Year in Review

Posted on Jul 2, 2015

2014 Annual Report Photo

Our not-for-profit Sutter Health network invites you to explore our online 2014 annual report. Through videos and other interactive features, see how our doctors, hospitals and medical teams partner to provide top-rated, personalized care in diverse communities across Northern California. This year our annual report focuses on our:
Year in review
Community support
Generous donors
Sutter Health family
“At Sutter Health, we understand that in a rapidly changing world we must reimagine how we operate if we want to continue delivering the kind of quality care our patients expect and deserve,” said Sutter Health President and CEO Pat Fry. “In 2014, we implemented advanced technologies, pursued groundbreaking research, streamlined work processes and launched more convenient ways to access care.”

SEBMF Physician is a Leading Researcher for Libido-Enhancing Drug for Women

Posted on Jun 5, 2015


Risa Kagan, M.D., a gynecologist with Sutter East Bay Medical Foundation is nationally recognized for her work and research in the field of menopause.

Yesterday’s testimony before the Food and Drug Administration on ‘the little pink pill’ Flibanserin has been hailed by many as a milestone in gender biased pharmaceuticals addressing sexual drive and libido.

Sutter East Bay Medical Foundation OB/GYN, Risa Kagan, M.D., was on the committee of medical experts and was a Principal Investigator for the drug for pre-menopausal and post menopausal women. “There are currently no drugs approved for female sexual function (while there are 26 drugs approved for males). With this vote we are one step closer to having an approved option for women. We can have a safety discussion that is well informed, monitored and updated, as opposed to the quackery and off-label treatments patients currently resort to,” said Kagan.

The FDA’s joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee determined by an 18 to 6 vote that the benefit/risk profile of flibanserin approval of the new drug.

Dr. Kagan is an obstetrician-gynecologist on staff with Alta Bates Summit Medical Center. She has been in practice for 37 years. Congratulations to Dr. Kagan on her research efforts through Alta Bates Summit’s REDI (Jordan Research and Education Institute).